{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [["Anti-viral", "COVID-19", "Integrative medicine", "Oxygen therapy", "Ozone therapy", "SARS-COV-2"]], "CitationSubset": ["IM"], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "33421928", "DateCompleted": {"Year": "2021", "Month": "02", "Day": "02"}, "DateRevised": {"Year": "2022", "Month": "12", "Day": "21"}, "Article": {"Language": ["eng"], "ArticleDate": [{"Year": "2020", "Month": "12", "Day": "23"}], "ELocationID": ["10.1016/j.intimp.2020.107301", "S1567-5769(20)33768-1"], "Journal": {"ISSN": "1878-1705", "JournalIssue": {"Volume": "91", "PubDate": {"Year": "2021", "Month": "Feb"}}, "Title": "International immunopharmacology", "ISOAbbreviation": "Int Immunopharmacol"}, "ArticleTitle": "Safety and efficacy of ozone therapy in mild to moderate COVID-19 patients: A phase 1/11 randomized control trial (SEOT study).", "Pagination": {"StartPage": "107301", "MedlinePgn": "107301"}, "Abstract": {"AbstractText": ["The Corona virus disease 19 (COVID-19) has accounted for multiple deaths and economic woes.While the entire medical fraternity and scientists are putting their best feet forward to find a solution to contain this deadly pandemic, there is a growing interest in integrating other known alternative therapies in to standard care. This study is aimed at evaluating the safety and efficacy of ozone therapy (OT), as an adjuvant to the standard of care (SOC).", "In the current randomized control trial, 60 patients with mild to moderate score NEWS score were included in two parallel groups (n\u00a0=\u00a030/group). The interventional group (OZ) received ozonized rectal insufflation and minor auto haemotherapy, daily along with SOC, while the control group (ST) received SOC alone. The main outcome measures included changes in clinical features, oxygenation index (SpO<sub>2</sub>), NEWS score, Reverse transcription polymerase chain reaction(RT-PCR), inflammatory markers, requirement of advanced care, and metabolic profiles.", "The OZ group has shown clinically significant improvement in the mean values of all the parameters tested compared to ST Group. However, statistical significance were only observed in RT-PCR negative reaction (P\u00a0=\u00a00.01), changes in clinical symptoms (P\u00a0<\u00a00.05) and requirement for Intensive care (P\u00a0<\u00a00.05). No adverse events were reported in OZ group, as against 2 deaths reported in ST group.", "OT when integrated with SOC can improve the clinical status and rapidly reduce the viral load compared to SOC alone, which facilitate early recovery and check the need for advanced care and mortality as demonstrated in this study."], "CopyrightInformation": "Copyright \u00a9 2020 Elsevier B.V. All rights reserved."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Training and Education Department, President of Ozone Forum of India, Mumbai, India."}], "LastName": "Shah", "ForeName": "Mili", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Head of the Clinical Department, Director of Ozone Forum of India, Mumbai, India."}], "LastName": "Captain", "ForeName": "Jignasha", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Trustee in Department of Ozone Therapy, Lokmanya Medical Research Centre, Pune, India. Electronic address: vgvaidya178@gmail.com."}], "LastName": "Vaidya", "ForeName": "Vidyadhar", "Initials": "V"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Oncology, Integrated Cancer Treatment and Research Centre, Wagholi, Pune, India."}], "LastName": "Kulkarni", "ForeName": "Arvind", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Ozone Therapy, Lokmanya Medical Research Centre, Pune, India."}], "LastName": "Valsangkar", "ForeName": "Kedar", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Indian Academy for Scientific Writing and Research, Pune, India. Electronic address: director@iaswar.com."}], "LastName": "Nair", "ForeName": "Pradeep M K", "Initials": "PMK"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Clinical Research, Department of Ozone Therapy, Lokmanya Medical Research Centre, Pune, India."}], "LastName": "Ganu", "ForeName": "Gayatri", "Initials": "G"}], "PublicationTypeList": ["Clinical Trial, Phase I", "Journal Article", "Randomized Controlled Trial"]}, "MedlineJournalInfo": {"Country": "Netherlands", "MedlineTA": "Int Immunopharmacol", "NlmUniqueID": "100965259", "ISSNLinking": "1567-5769"}, "ChemicalList": [{"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Adult"}, {"QualifierName": ["therapy"], "DescriptorName": "COVID-19"}, {"QualifierName": ["methods"], "DescriptorName": "Critical Care"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Middle Aged"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Ozone"}, {"QualifierName": ["prevention & control"], "DescriptorName": "Pandemics"}, {"QualifierName": ["drug effects"], "DescriptorName": "SARS-CoV-2"}, {"QualifierName": [], "DescriptorName": "Standard of Care"}, {"QualifierName": [], "DescriptorName": "Treatment Outcome"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Mo P., Xing Y., Xiao Y., Deng L., Zhao Q., Wang H., Xiong Y., Cheng Z., Gao S., Liang K., Luo M., Chen T., Song S., Ma Z., Chen X., Zheng R., Cao Q., Wang F., Zhang Y. Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China. Clin. Infect. Dis. 2020 doi: 10.1093/cid/ciaa270.", "ArticleIdList": ["10.1093/cid/ciaa270", "PMC7184444", "32173725"]}, {"Citation": "Florindo H.F., Kleiner R., Vaskovich-Koubi D., Ac\u00farcio R.C., Carreira B., Yeini E., Tiram G., Liubomirski Y., Satchi-Fainaro R. Immune-mediated approaches against COVID-19. Nat. Nanotechnol. 2020;15:630\u2013645. doi: 10.1038/s41565-020-0732-3.", "ArticleIdList": ["10.1038/s41565-020-0732-3", "PMC7355525", "32661375"]}, {"Citation": "H. Ouassou, L. Kharchoufa, M. Bouhrim, N.E. Daoudi, H. Imtara, N. Bencheikh, A. ELbouzidi, M. Bnouham, The Pathogenesis of Coronavirus Disease 2019 (COVID-19): Evaluation and Prevention, J. Immunol. Res. 2020 (2020) 1357983. https://doi.org/10.1155/2020/1357983.", "ArticleIdList": ["PMC7352127", "32671115"]}, {"Citation": "Matthay M.A., Aldrich J.M., Gotts J.E. Treatment for severe acute respiratory distress syndrome from COVID-19. Lancet Respir. Med. 2020;8:433\u2013434. doi: 10.1016/S2213-2600(20)30127-2.", "ArticleIdList": ["10.1016/S2213-2600(20)30127-2", "PMC7118607", "32203709"]}, {"Citation": "Tillu G., Chaturvedi S., Chopra A., Patwardhan B. Public Health Approach of Ayurveda and Yoga for COVID-19 Prophylaxis. J. Altern. Complement. Med. 2020;26:360\u2013364. doi: 10.1089/acm.2020.0129.", "ArticleIdList": ["10.1089/acm.2020.0129", "32310670"]}, {"Citation": "Golechha M. Time to realise the true potential of Ayurveda against COVID-19. Brain. Behav. Immun. 2020;87:130\u2013131. doi: 10.1016/j.bbi.2020.05.003.", "ArticleIdList": ["10.1016/j.bbi.2020.05.003", "PMC7204691", "32389701"]}, {"Citation": "A. Hern\u00e1ndez, P.J. Papadakos, A. Torres, D.A. Gonz\u00e1lez, M. Vives, C. Ferrando, J. Baeza, Two known therapies could be useful as adjuvant therapy in critical patients infected by COVID-19, Rev. Espa\u00f1ola Anestesiol. y Reanim. (English Ed. 67 (2020) 245\u2013252. https://doi.org/https://doi.org/10.1016/j.redare.2020.05.002.", "ArticleIdList": ["PMC7156242", "32303365"]}, {"Citation": "M. Yang, Z. Hu, R. Yue, Efficacy and safety of Chinese herbal medicine for Coronavirus disease 2019: A protocol for systematic review and meta-analysis, Medicine (Baltimore). 99 (2020). https://journals.lww.com/md-journal/Fulltext/2020/05290/Efficacy_and_safety_of_Chinese_herbal_medicine_for.25.aspx.", "ArticleIdList": ["32481380"]}, {"Citation": "Rowen R.J. Ozone therapy as a primary and sole treatment for acute bacterial infection: case report. Med. Gas Res. 2018;8:121\u2013124. doi: 10.4103/2045-9912.241078.", "ArticleIdList": ["10.4103/2045-9912.241078", "PMC6178636", "30319768"]}, {"Citation": "Dubuis M.-E., Dumont-Leblond N., Lalibert\u00e9 C., Veillette M., Turgeon N., Jean J., Duchaine C. Ozone efficacy for the control of airborne viruses: Bacteriophage and norovirus models. PLoS One. 2020;15 doi: 10.1371/journal.pone.0231164.", "ArticleIdList": ["10.1371/journal.pone.0231164", "PMC7147755", "32275685"]}, {"Citation": "Rowen R. Ozone and oxidation therapies as a solution to the emerging crisis in infectious disease management: a review of current knowledge and experience. Med. Gas Res. 2019;9:232\u2013237. doi: 10.4103/2045-9912.273962.", "ArticleIdList": ["10.4103/2045-9912.273962", "PMC7802416", "31898609"]}, {"Citation": "Bocci V.A. Scientific and medical aspects of ozone therapy. State of the art. Arch. Med. Res. 2006;37:425\u2013435. doi: 10.1016/j.arcmed.2005.08.006.", "ArticleIdList": ["10.1016/j.arcmed.2005.08.006", "16624639"]}, {"Citation": "Franzini M., Valdenassi L., Ricevuti G., Chirumbolo S., Depfenhart M., Bertossi D., Tirelli U. Oxygen-ozone (O(2)-O(3)) immunoceutical therapy for patients with COVID-19. Preliminary evidence reported. Int. Immunopharmacol. 2020;88 doi: 10.1016/j.intimp.2020.106879.", "ArticleIdList": ["10.1016/j.intimp.2020.106879", "PMC7414302", "32795898"]}, {"Citation": "Mart\u00ednez-S\u00e1nchez G., Schwartz A., Di Donna V. Potential Cytoprotective Activity of Ozone Therapy in SARS-CoV-2/COVID-19. Antioxidants (Basel, Switzerland) 2020;9:389. doi: 10.3390/antiox9050389.", "ArticleIdList": ["10.3390/antiox9050389", "PMC7278582", "32384798"]}, {"Citation": "Gavazza A., Marchegiani A., Rossi G., Franzini M., Spaterna A., Mangiaterra S., Cerquetella M. Ozone Therapy as a Possible Option in COVID-19 Management. Front. Public Heal. 2020;8:417. doi: 10.3389/fpubh.2020.00417.", "ArticleIdList": ["10.3389/fpubh.2020.00417", "PMC7477102", "32984235"]}, {"Citation": "Zheng Z., Dong M., Hu K. A preliminary evaluation on the efficacy of ozone therapy in the treatment of COVID-19. J. Med. Virol. 2020;92:2348\u20132350. doi: 10.1002/jmv.26040.", "ArticleIdList": ["10.1002/jmv.26040", "PMC7280732", "32437014"]}, {"Citation": "Fern\u00e1ndez-Cuadros M.E., Albaladejo-Flor\u00edn M.J., Pe\u00f1a-Lora D., \u00c1lava-Rabasa S., P\u00e9rez-Moro O.S. Ozone (O3) and SARS-CoV-2: Physiological Bases and Their Therapeutic Possibilities According to COVID-19 Evolutionary Stage, SN Compr. Clin. Med. 2020:1\u20139. doi: 10.1007/s42399-020-00328-7.", "ArticleIdList": ["10.1007/s42399-020-00328-7", "PMC7340747", "32838159"]}, {"Citation": "Jones M. NEWSDIG: The National Early Warning Score Development and Implementation Group. Clin. Med. 2012;12:501\u2013503. doi: 10.7861/clinmedicine.12-6-501.", "ArticleIdList": ["10.7861/clinmedicine.12-6-501", "PMC5922584", "23342400"]}, {"Citation": "Clinical Management Protocol: COVID-19, India, 2020. https://www.mohfw.gov.in/pdf/ClinicalManagementProtocolforCOVID19.pdf."}, {"Citation": "Fern\u00e1ndez-Cuadros M.E., Albaladejo-Flor\u00edn M.J., \u00c1lava-Rabasa S., Usandizaga-Elio I., Martinez-Quintanilla Jimenez D., Pe\u00f1a-Lora D., Neira-Borrajo I., L\u00f3pez-Mu\u00f1oz M.J., Rodr\u00edguez-de-C\u00eda J., P\u00e9rez-Moro O.S. Effect of Rectal Ozone (O(3)) in Severe COVID-19 Pneumonia: Preliminary Results, SN Compr. Clin. Med. 2020:1\u20139. doi: 10.1007/s42399-020-00374-1.", "ArticleIdList": ["10.1007/s42399-020-00374-1", "PMC7397966", "32838181"]}, {"Citation": "Hu B., Zheng J., Liu Q., Yang Y., Zhang Y. The effect and safety of ozone autohemotherapy combined with pharmacological therapy in postherpetic neuralgia. J. Pain Res. 2018;11:1637\u20131643. doi: 10.2147/JPR.S154154.", "ArticleIdList": ["10.2147/JPR.S154154", "PMC6118245", "30214273"]}, {"Citation": "Cattel F., Giordano S., Bertiond C., Lupia T., Corcione S., Scaldaferri M., Angelone L., De Rosa F.G. Ozone therapy in COVID-19: A narrative review. Virus Res. 2021;291 doi: 10.1016/j.virusres.2020.198207.", "ArticleIdList": ["10.1016/j.virusres.2020.198207", "PMC7585733", "33115670"]}, {"Citation": "Valdenassi U.T.L., Franzini M., Ricevuti G., Rinaldi L., Galoforo A.C. Potential mechanisms by which the oxygen-ozone (O2\u2013O3) therapy could contribute to the treatment against the coronavirus COVID-19. Eur Rev Med Pharmacol Sci. 2020;24:4059\u20134061.", "ArticleIdList": ["32374009"]}, {"Citation": "Kashani K.B. Hypoxia in COVID-19: Sign of Severity or Cause for Poor Outcomes. Mayo Clin. Proc. 2020;95:1094\u20131096. doi: 10.1016/j.mayocp.2020.04.021.", "ArticleIdList": ["10.1016/j.mayocp.2020.04.021", "PMC7177114", "32498766"]}, {"Citation": "C. Wu, X. Chen, Y. Cai, J. Xia, X. Zhou, S. Xu, H. Huang, L. Zhang, X. Zhou, C. Du, Y. Zhang, J. Song, S. Wang, Y. Chao, Z. Yang, J. Xu, X. Zhou, D. Chen, W. Xiong, L. Xu, F. Zhou, J. Jiang, C. Bai, J. Zheng, Y. Song, Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China, JAMA Intern. Med. 180 (2020) 934\u2013943. https://doi.org/10.1001/jamainternmed.2020.0994.", "ArticleIdList": ["PMC7070509", "32167524"]}, {"Citation": "F. Araimo, C. Imperiale, P. Tordiglione, G. Ceccarelli, C. Borrazzo, F. Alessandri, L. Santinelli, G. Pietro Innocenti, C. Pinacchio, V. Mauro, G.E. Recchia, S. Zancla, A. Cal\u00f2, R. Poscia, F. Ruberto, G. d\u2019Ettorre, F. Bilotta, C. Mastroianni, F. Pugliese, Ozone as adjuvant support in the treatment of COVID-19: A preliminary report of probiozovid trial, J. Med. Virol. n/a (2020). https://doi.org/10.1002/jmv.26636.", "ArticleIdList": ["33111980"]}, {"Citation": "Li J., Chen Z., Nie Y., Ma Y., Guo Q., Dai X. Identification of Symptoms Prognostic of COVID-19 Severity: Multivariate Data Analysis of a Case Series in Henan Province. J Med Internet Res. 2020;22 doi: 10.2196/19636.", "ArticleIdList": ["10.2196/19636", "PMC7332230", "32544071"]}, {"Citation": "Williamson B.N., Feldmann F., Schwarz B., Meade-White K., Porter D.P., Schulz J., van Doremalen N., Leighton I., Yinda C.K., P\u00e9rez-P\u00e9rez L., Okumura A., Lovaglio J., Hanley P.W., Saturday G., Bosio C.M., Anzick S., Barbian K., Cihlar T., Martens C., Scott D.P., Munster V.J., de Wit E. Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2. Nature. 2020;585:273\u2013276. doi: 10.1038/s41586-020-2423-5.", "ArticleIdList": ["10.1038/s41586-020-2423-5", "PMC7486271", "32516797"]}, {"Citation": "Williams A.S., Nath P., Leung S.-Y., Khorasani N., McKenzie A.N.J., Adcock I.M., Chung K.F. Modulation of ozone-induced airway hyperresponsiveness and inflammation by interleukin-13. Eur. Respir. J. 2008;32:571\u2013578. doi: 10.1183/09031936.00121607.", "ArticleIdList": ["10.1183/09031936.00121607", "18417511"]}], "ReferenceList": []}], "History": [{"Year": "2020", "Month": "10", "Day": "31"}, {"Year": "2020", "Month": "12", "Day": "10"}, {"Year": "2020", "Month": "12", "Day": "11"}, {"Year": "2021", "Month": "1", "Day": "10", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "2", "Day": "3", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "1", "Day": "9", "Hour": "20", "Minute": "15"}, {"Year": "2020", "Month": "12", "Day": "23"}], "PublicationStatus": "ppublish", "ArticleIdList": ["33421928", "PMC7758022", "10.1016/j.intimp.2020.107301", "S1567-5769(20)33768-1"]}}], "PubmedBookArticle": []}